Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hengming Ke

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
The Journal of Biological Chemistry|March 27, 2015
The MDM2 RING domain and central acidic domain play distinct roles in MDM2 protein homodimerization and MDM2-MDMX protein heterodimerizationPatrick L Leslie, Hengming Ke, Yanping Zhang
Future Medicinal Chemistry|August 24, 2011
Phosphodiesterase inhibitors as a new generation of antiprotozoan drugs: exploiting the benefit of enzymes that are highly conserved between host and parasiteThomas Seebeck, Geert Jan Sterk, Hengming Ke
Methods in Molecular Biology (Clifton, N.J.)|July 1, 2005
Crystallization of cyclic nucleotide phosphodiesterasesHengming Ke, Qing Huai, Robert X Xu
Molecular Pharmacology|December 26, 2001
Molecular docking of competitive phosphodiesterase inhibitorsOrly Dym, Ioannis Xenarios, Hengming Ke, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2007
High-resolution design of a protein loopXiaozhen Hu, Huanchen Wang, Hengming Ke, et al.
Protein Expression and Purification|November 6, 2008
Refolding and kinetic characterization of the phosphodiesterase-8A catalytic domainZier Yan, Huanchen Wang, Jiwen Cai, et al.
Structure (London, England : 1993)|December 17, 2008
Computer-based redesign of a beta sandwich protein suggests that extensive negative design is not required for de novo beta sheet designXiaozhen Hu, Huanchen Wang, Hengming Ke, et al.
The Journal of Biological Chemistry|July 5, 2005
Multiple elements jointly determine inhibitor selectivity of cyclic nucleotide phosphodiesterases 4 and 7Huanchen Wang, Yudong Liu, Yuxiang Chen, et al.
Journal of Medicinal Chemistry|April 8, 2020
Advances in the Development of Phosphodiesterase-4 InhibitorsTing Peng, Baowen Qi, Jun He, et al.
Medicinal Research Reviews|January 27, 2024
Emerging phosphodiesterase inhibitors for treatment of neurodegenerative diseasesYu Xiang, Swapna Naik, Liyun Zhao, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
The Journal of Biological Chemistry|March 27, 2015
The MDM2 RING domain and central acidic domain play distinct roles in MDM2 protein homodimerization and MDM2-MDMX protein heterodimerizationPatrick L Leslie, Hengming Ke, Yanping Zhang
Future Medicinal Chemistry|August 24, 2011
Phosphodiesterase inhibitors as a new generation of antiprotozoan drugs: exploiting the benefit of enzymes that are highly conserved between host and parasiteThomas Seebeck, Geert Jan Sterk, Hengming Ke
Methods in Molecular Biology (Clifton, N.J.)|July 1, 2005
Crystallization of cyclic nucleotide phosphodiesterasesHengming Ke, Qing Huai, Robert X Xu
Molecular Pharmacology|December 26, 2001
Molecular docking of competitive phosphodiesterase inhibitorsOrly Dym, Ioannis Xenarios, Hengming Ke, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2007
High-resolution design of a protein loopXiaozhen Hu, Huanchen Wang, Hengming Ke, et al.
Protein Expression and Purification|November 6, 2008
Refolding and kinetic characterization of the phosphodiesterase-8A catalytic domainZier Yan, Huanchen Wang, Jiwen Cai, et al.
Structure (London, England : 1993)|December 17, 2008
Computer-based redesign of a beta sandwich protein suggests that extensive negative design is not required for de novo beta sheet designXiaozhen Hu, Huanchen Wang, Hengming Ke, et al.
The Journal of Biological Chemistry|July 5, 2005
Multiple elements jointly determine inhibitor selectivity of cyclic nucleotide phosphodiesterases 4 and 7Huanchen Wang, Yudong Liu, Yuxiang Chen, et al.
Journal of Medicinal Chemistry|April 8, 2020
Advances in the Development of Phosphodiesterase-4 InhibitorsTing Peng, Baowen Qi, Jun He, et al.
Medicinal Research Reviews|January 27, 2024
Emerging phosphodiesterase inhibitors for treatment of neurodegenerative diseasesYu Xiang, Swapna Naik, Liyun Zhao, et al.
Pageof 7